A study to view the effects of a drug Levobupivacaine, used to provide muscle paralysis and insensitivity to pain in surgeries .

Not yet recruiting

• Conditions: Medical and Surgical, (2) ICD-10 Condition: O||Medical and Surgical,

• Registration Number: CTRI/2023/10/058526
• Lead Sponsor: Dr B R Ambedkar medical College and hospital

Brief Summary

**HYPERBARIC LEVOBUPIVACAINE 0.5% IS A SAFER DRUG FOR SPINAL ANAESTHESIA , THIS STUDY IS TO OBSERVE THE CLINICAL EFFECTS OF HYPERBARIC LEVOBUPIVACAINE**

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-07-10
• Study Start: 2023-10-20

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• A)All patients aged between 18 to 60 years of age posted for elective surgeries under spinal anaesthesia.
• b) ASA grade I and II patient.

Exclusion Criteria

patients with bleeding and coagulation disorders and local site infections are excluded.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the total duration of analgesia with intrathecal 0.5% hyperbaric levobupivacaine.	every two hours

Secondary Outcome Measures

Name	Time	Method
1)Sensory Block	a)Maximum height of block achieved

Trial Locations

Locations (1)

OT complex, DR. B.R. AMBEDKAR MEDICAL COLLEGE AND HOSPITAL; 🇮🇳 Bangalore, KARNATAKA, India

OT complex, DR. B.R. AMBEDKAR MEDICAL COLLEGE AND HOSPITAL

🇮🇳Bangalore, KARNATAKA, India

DR VISHNU VC

Principal investigator

7592068345

vcvishnu007@gmail.com